1. Home
  2. NEON vs ATHA Comparison

NEON vs ATHA Comparison

Compare NEON & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.90

Market Cap

32.1M

Sector

Technology

ML Signal

HOLD

Logo Athira Pharma Inc.

ATHA

Athira Pharma Inc.

HOLD

Current Price

$6.75

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
ATHA
Founded
1997
2011
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1M
26.0M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
NEON
ATHA
Price
$1.90
$6.75
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
212.9K
3.2M
Earning Date
11-06-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$2,197,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.34
N/A
P/E Ratio
$3.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$2.20
52 Week High
$29.90
$8.36

Technical Indicators

Market Signals
Indicator
NEON
ATHA
Relative Strength Index (RSI) 37.68 57.44
Support Level $1.85 $6.41
Resistance Level $1.96 $7.45
Average True Range (ATR) 0.09 0.67
MACD 0.03 -0.05
Stochastic Oscillator 48.48 27.14

Price Performance

Historical Comparison
NEON
ATHA

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: